Risk factors, Psychosocial Correlates and Health-related Quality of Life in Nigerian with Irritable Bowel Syndrome: A Community-based Study

Abiodun Christopher Jemilohun, Kolawole Oluseyi Akande, Charles John Elikwu, Oluwatoyin Adetutu Fasesan, Olufunke Oluwatosin Adeleye, Theophilus Oludare Ajiro


Background: Irritable bowel syndrome (IBS) occurs worldwide and portends a huge socioeconomic burden to the individual and society. Though extensively investigated in some other regions, IBS has not been adequately studied in sub-Saharan African. We studied the prevalence of IBS, its risk factors and the health-related quality of life in a Nigerian community.

Methods: We interviewed 515 consenting adults aged 18 – 70 years in a Nigerian community. We collected data from the participants with a composite questionnaire consisting of the Rome IV Functional Bowel Disorder questionnaire, the Becks Anxiety and Depression Inventories, the Pittsburgh Sleep Quality Index, the Early Trauma Inventory-Self Report, Short Form 12, version 2 Health Survey (SF-12v2) questionnaire and other relevant questions. Data analysis was done with appropriate statistical instruments.

Results: We included 505 participants in the data analysis. Participants’ mean age was 32.7 ±12.9 years. The prevalence of IBS was 3.6% (95% CI = 2.0% - 5.3%). IBS had statistically significant relationship with anxiety [OR = 1.09 (1.03 – 1.15), P = 0.002] and low educational attainment [OR = 5.73 (95% CI, 1.52 -21.61), P = 0.010]. The mean scores of the SF-12v2 8 scales, except vitality, were lower in subjects with IBS than the controls. The relationship was statistically significant in all the scales (P ≤ 0.05), except general health and vitality.

Conclusion:  IBS is positively associated with anxiety, low educational attainment and poor health-related quality of life. Clinicians need to pay attention to the mental health and quality of life of their patients with IBS.


Irritable bowel syndrome; Psychopathology; Anxiety; Depression; Health-related quality of life


Lacy BE, Mearin F, Chang L, Chey WD, Lembo AJ, Simren M, Spiller R. Bowel Disorders. Gastroenterology. 2016;150:1393-1407. [PMID: 27144627]; [DOI: 10.1053/j.gastro.2016.02.031]

Whitehead WE, Drossman, DA, Chang L, Chey WD, Kellwow J, Tack J. Rome IV Diagnostic Questionnaires and Tables for Investigators and Clinicians. 1st ed. Raleigh, North Carolina: Rome Foundation, 2017.

Canavan C, West J, Card T. The epidemiology of irritable bowel syndrome. Clin Epidemiol. 2014;6:71–80. [PMID: 24523597]; [DOI: 10.2147/CLEP.S40245]

Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10:712-721.e4. [PMID: 22426087]; [DOI: 10.1016/j.cgh.2012.02.029]

Drossman DA. Functional Gastrointestinal Disorders: History, Pathophysiology, Clinical Features, and Rome IV. Gastroenterology. 201619;150:1262-1279. [PMID: 27144617]; [DOI: 10.1053/j.gastro.2016.02.032]

Ibrahim NK. A systematic review of the prevalence and risk factors of irritable bowel syndrome among medical students. Turk J Gastroenterol. 2016;27:10–16. [PMID: 26674980]; [DOI: 10.5152/tjg.2015.150333]

Butt AS, Salih M, Jafri W, Yakoob J, Wasay M, Hamid S. Irritable bowel syndrome and psychiatric disorders in Pakistan: a case control study. Gastroenterol Res Pract. 2012;2012:291452. [PMID: 22505882]; [DOI: 10.1155/2012/291452]

Lee Y-T, Hu L-Y, Shen C-C, et al. Risk of Psychiatric Disorders following Irritable Bowel Syndrome: A Nationwide Population-Based Cohort Study. PloS One. 2015;10:e0133283. [PMID: 26222511]; [DOI: 10.1371/journal.pone.0133283]

Surdea-Blaga T, Băban A, Dumitrascu DL. Psychosocial determinants of irritable bowel syndrome. World J Gastroenterol. 2012;18:616–26. [PMID: 22363132]; [DOI: 10.3748/wjg.v18.i7.616]

Fadgyas-Stanculete M, Buga A-M, Popa-Wagner A, Dumitrascu DL. The relationship between irritable bowel syndrome and psychiatric disorders: from molecular changes to clinical manifestations. J Mol Psychiatry. 2014;2:4. [PMID: 25408914]; [DOI: 10.1186/2049-9256-2-4]

Saha L. Irritable bowel syndrome: pathogenesis, diagnosis, treatment, and evidence-based medicine. World J Gastroenterol. 2014;20:6759–6773. [PMID: 24944467]; [DOI: 10.3748/wjg.v20.i22.6759]

Talley NJ, Gabriel SE, Harmsen WS, Zinsmeister AR, Evans RW. Medical costs in community subjects with irritable bowel syndrome. Gastroenterology. 1995;109:1736–1741. [PMID: 7498636]; [DOI: 10.1016/0016-5085(95)90738-6]

Hahn BA, Yan S, Strassels S. Impact of irritable bowel syndrome on quality of life and resource use in the United States and United Kingdom. Digestion. 1999;60:77–81. [PMID: 9892803]; [DOI: 10.1159/000007593]

Fullerton S. Functional digestive disorders (FDD) in the year 2000--economic impact. Eur J Surg Suppl. 1998;582(Suppl):62–64. [PMID: 10029367]; [DOI: 10.1080/11024159850191463]

Nellesen D, Yee K, Chawla A, Lewis BE, Carson RT. A systematic review of the economic and humanistic burden of illness in irritable bowel syndrome and chronic constipation. J Manag Care Pharm. 2013;19:755–764. [PMID: 24156644]; [DOI: 10.18553/jmcp.2013.19.9.755]

Zhang F, Xiang W, Li C-Y, Li S-C. Economic burden of irritable bowel syndrome in China. World J Gastroenterol. 2016;22:10450–1060. [PMID: 28058026]; [DOI: 10.3748/wjg.v22.i47.10450]

Brandt LJ, Chey WD, Foxx-Orenstein AE, Lawrence, Schiller LR, Schoenfeld PS, Spiegel BM, Talley NJ, Quigley EMM. An evidence-based position statement on the management of irritable bowel syndrome. Am J Gastroenterol. 2009;104(Suppl 1):S1-35. [PMID: 19521341] [DOI: 10.1038/ajg.2008.122]

Okeke EN, Ladep NG, Adah S, Bupwatda PW, Agaba EI, Malu AO. Prevalence of irritable bowel syndrome: a community survey in an African population. Ann Afr Med. 2009;8:177–180. [PMID: 19884695]; [DOI: 10.4103/1596-3519.57241]

Nwokediuko SC, Adekanle O, Akere A, et al. Irritable bowel syndrome in Nigeria: Disparity between the North and the South. Nigerian J Gastroenterol Hepatol. 2019; 11:9-14

The Authors. Functional Bowel Disorders, Psychosocial Correlates and Health-related Quality of Life in a Nigerian Community: Ilisan-Remo Functional Bowel Disorders Project Protocol. Int Res J Gastroenterol Hepatol. 2020;3:1–9.

Vanner SJ, Depew WT, Paterson WG, et al. Predictive value of the Rome criteria for diagnosing the irritable bowel syndrome. Am J Gastroenterol. 1999;94:2912–2917. [PMID: 10520844]; [DOI: 10.1111/j.1572-0241.1999.01437.x]

Dong Y-Y, Zuo X-L, Li C-Q, Yu Y-B, Zhao Q-J, Li Y-Q. Prevalence of irritable bowel syndrome in Chinese college and university students assessed using Rome III criteria. World J Gastroenterol. 2010;16:4221–4226. [PMID: 20806442]; [DOI: 10.3748/wjg.v16.i33.4221]

Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol. 1988;56:893–897. [PMID: 3204199]; [DOI: 10.1037//0022-006x.56.6.893]

Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:561–571. [PMID: 13688369]; [DOI: 10.1001/archpsyc.1961.01710120031004]

Bremner JD, Bolus R, Mayer EA. Psychometric properties of the Early Trauma Inventory-Self Report. J Nerv Ment Dis. 2007;195:211–218. [PMID: 17468680]; [DOI: 10.1097/01.nmd.0000243824.84651.6c]

Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–213. [PMID: 2748771]; [DOI: 10.1016/0165-1781(89)90047-4]

Ware J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–233. [PMID: 8628042]; [DOI: 10.1097/00005650-199603000-00003]

International Quality of Life Assessment - IQOLA Countries, cited 2020-09-01. Available from: URL: http://www.iqola.org/countries.aspx

Chang F-Y, Lu C-L, Chen T-S. The Current Prevalence of Irritable Bowel Syndrome in Asia. J Neurogastroenterol Motil. 2010;16:389–400. [PMID: 21103420]; [DOI: 10.5056/jnm.2010.16.4.389]

Hillilä MT, Färkkilä MA. Prevalence of irritable bowel syndrome according to different diagnostic criteria in a non-selected adult population. Aliment Pharmacol Ther. 2004;20:339–345. [PMID: 15274671]; [DOI: 10.1111/j.1365-2036.2004.02034.x]

Bai T, Xia J, Jiang Y, Cao H, Zhao Y, Zhang L , Wang H, Song J, Xiaohua Hou X. Comparison of the Rome IV and Rome III criteria for IBS diagnosis: A cross-sectional survey. J Gastroenterol Hepatol. 2017;32:1018–1025. [PMID: 27862281]; [DOI: 10.1111/jgh.13642]

Vork L, Weerts ZZRM, Mujagic Z, Kruimel JW , Hesselink MAM, Muris JWM, Keszthelyi D, Jonkers DMAE, Masclee AAM. Rome III vs Rome IV criteria for irritable bowel syndrome: A comparison of clinical characteristics in a large cohort study. Neurogastroenterol Motil. 2018;30. [PMID: 28804974]; [DOI: 10.1111/nmo.13189]

Aziz I, Törnblom H, Palsson OS, Whitehead WE, Simrén M. How the Change in IBS Criteria From Rome III to Rome IV Impacts on Clinical Characteristics and Key Pathophysiological Factors. Am J Gastroenterol. 2018;113:1017–1025. [PMID: 29880963]; [DOI: 10.1038/s41395-018-0074-z]

Black CJ, Yiannakou Y, Houghton LA, Ford AC. Epidemiological, Clinical, and Psychological Characteristics of Individuals with Self-reported Irritable Bowel Syndrome Based on the Rome IV vs Rome III Criteria. Clin Gastroenterol Hepatol. 2020;18:392-398. [PMID: 31154027]; [DOI: 10.1016/j.cgh.2019.05.037]

Böhn L, Störsrud S, Törnblom H, Bengtsson U, Simrén M. Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. Am J Gastroenterol. 2013;10:634–641. [PMID: 23644955]; [DOI: 10.1038/ajg.2013.105]

Shepherd SJ, Lomer MCE, Gibson PR. Short-chain carbohydrates and functional gastrointestinal disorders. Am J Gastroenterol. 2013;108:707–717. [PMID: 23588241]; [DOI: 10.1038/ajg.2013.96]

Lovell RM, Ford AC. Effect of gender on prevalence of irritable bowel syndrome in the community: systematic review and meta-analysis. Am J Gastroenterol. 2012;107:991–1000. [PMID: 22613905]; [DOI: 10.1038/ajg.2012.131]

Ladep NG, Obindo TJ, Audu MD, Okeke EN, Malu AO. Depression in patients with irritable bowel syndrome in Jos, Nigeria. World J Gastroenterol. 2006;12:7844–7844. [PMID: 17203531]; [DOI: 10.3748/wjg.v12.i48.7844]

Jemilohun AC, Abayomi O, Adebayo PB. Prevalence of Irritable Bowel Syndrome, Psychological Ill-Health and Health-Seeking Behavior in a Population of Nigerian Medical Students. J Adv Med Med Res. 2018;25:1–9. [DOI: 10.9734/JAMMR/2018/39235]

Talley NJ, Spiller R. Irritable bowel syndrome: a little understood organic bowel disease? Lancet. 2002;360:555–564. [PMID: 12241674]; [DOI: 10.1016/S0140-6736(02)09712-X]

Edgerton JD, Roberts LW, von Below S. Education and Quality of Life. In: Land KC, Michalos AC, Sirgy MJ, editors. Handbook of Social Indicators and Quality of Life Research. Dordrecht, Netherlands: Springer, 2012: 265–296.

Drossman DA, Li Z, Andruzzi E, Temple RD, Talley NJ, Thompson WG, Whitehead WE, Janssens J, Funch-Jensen P, Corazziari E. U.S. householder survey of functional gastrointestinal disorders. Prevalence, sociodemography, and health impact. Dig Dis Sci. 1993;38:1569–1580. [PMID: 8359066]; [DOI: 10.1007/bf01303162]

Ford AC, Forman D, Bailey AG, Axon ATR, Moayyedi P. Irritable bowel syndrome: a 10-yr natural history of symptoms and factors that influence consultation behavior. Am J Gastroenterol. 2008;103:1229–1239. [PMID: 18371141], [DOI: 10.1111/j.1572-0241.2007.01740.x]

Mendall MA, Kumar D. Antibiotic use, childhood affluence and irritable bowel syndrome (IBS). Eur J Gastroenterol. Hepatol. 1998;10:59–62. [PMID: 9512954]; [DOI: 10.1097/00042737-199801000-00011]

Howell S, Talley NJ, Quine S, Poulton R. The irritable bowel syndrome has origins in the childhood socioeconomic environment. Am J Gastroenterol. 2004;99:1572–1578. [PMID: 15307879]; [DOI: 10.1111/j.1572-0241.2004.40188.x]

Silvernale C, Kuo B, Staller K. Lower socioeconomic status is associated with an increased prevalence of comorbid anxiety and depression among patients with irritable bowel syndrome: results from a multicenter cohort. Scand J Gastroenterol. 2019;54:1070–1074. [PMID: 31530048]; [DOI: 10.1080/00365521.2019.1665095]

Gralnek IM, Hays RD, Kilbourne A, Naliboff B, Mayer EA. The impact of irritable bowel syndrome on health-related quality of life. Gastroenterology. 2000;119:654–660. [PMID: 10982758]; [DOI: 10.1053/gast.2000.16484]

Frank L, Kleinman L, Rentz A, Ciesla G, Kim JJ, Zacker C. Health-related quality of life associated with irritable bowel syndrome: comparison with other chronic diseases. Clin Ther. 2002;24:675–689. [PMID: 12017411]; [DOI: 10.1016/s0149-2918(02)85143-8]

Full Text: PDF HTML


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.